Kriya Therapeutics

About:

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

Website: https://kriyatherapeutics.com

Twitter/X: kriyatx

Top Investors: Alumni Ventures, Foresite Capital, Woodline Partners, Patient Square Capital, Narya Capital

Description:

Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. They have built a fully integrated engine that consolidates the critical infrastructure and technology needed to engineer, manufacture, characterize, and develop new gene therapies

Total Funding Amount:

$601M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)kriyatx.com

Founders:

Fraser Wright, Roger Jeffs, Shankar Ramaswamy

Number of Employees:

101-250

Last Funding Date:

2023-07-26

IPO Status:

Private

© 2025 bioDAO.ai